Hawley Presses FDA on Medication Abortion Review

The letter follows reports that Makary planned to delay the review until after the 2026 midterm elections, sparking criticism from anti-abortion groups who urged President Donald Trump to remove him. Hawley asked Makary to clarify whether safety reviews have been postponed and if the FDA intends to reinstate in-person dispensing requirements.
Source